Skip to main content
SpringerLink
Log in

Preventing renal disease progression: Is it the drug or the blood pressure reduction, or both?

  • Invited Commentary
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Viberti G, Morgensen CE, Groop LC, Pauls LF, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994, 271:275–279.

    Article  PubMed  CAS  Google Scholar 

  2. Ravid M, Brosh D, Levi S, et al.: Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuria patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 1998, 128:982–988.

    PubMed  CAS  Google Scholar 

  3. Weir MR, Dworkin LD: Anti-hypertensive drugs, dietary salt, and renal protection: how low should you go with which therapy? Am J Kidney Dis 1998, 32:1–22.

    Article  PubMed  CAS  Google Scholar 

  4. Klag MJ, Whelton PK, Randall BL, et al.: Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334:13–18.

    Article  PubMed  CAS  Google Scholar 

  5. Modification of Diet in Renal Disease Study Group, Levey AS, Breyer JA, Faubert P, Rolin HA, Wang S-R, Writing Group: Effects of blood pressure control and progressive renal disease in blacks and whites. Hypertension 1997, 30:428–435.

    PubMed  Google Scholar 

  6. The Heart Outcomes Prevention Evaluation Study Investigators: Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med 2000, 342:154–160.

    Article  Google Scholar 

  7. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results from HOPE study and Micro-HOPE substudy. Lancet 2000, 355:253–259.

    Article  Google Scholar 

  8. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report. Arch Intern Med 1997, 157:2413–2446.

  9. Jafar TH, Schmid CH, Stark PC, et al.: The optimal level of blood pressure and urine protein excretion for the prevention of progression of chronic renal disease. J Am Soc Nephrol 2000, 11:63A.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Clinical Research Unit, Department of Medicine, University of Maryland School of Medicine, 22 S. Greene Street, 21201, Baltimore, MD, USA

    Matthew R. Weir MD

Authors
  1. Matthew R. Weir MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weir, M.R. Preventing renal disease progression: Is it the drug or the blood pressure reduction, or both?. Curr Hypertens Rep 2, 497–499 (2000). https://doi.org/10.1007/s11906-996-0030-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-996-0030-y

Keywords

Search

Navigation